Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Revenue (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Revenue for 5 consecutive years, with -$136000.0 as the latest value for Q4 2025.

  • Quarterly Revenue changed N/A to -$136000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.6 million for FY2023, 83.69% down from the prior year.
  • Revenue for Q4 2025 was -$136000.0 at Pliant Therapeutics, up from -$815000.0 in the prior quarter.
  • The five-year high for Revenue was $5.0 million in Q2 2022, with the low at -$815000.0 in Q3 2025.
  • Average Revenue over 4 years is $1.2 million, with a median of $1.4 million recorded in 2022.
  • The sharpest move saw Revenue soared 178.87% in 2022, then plummeted 95.03% in 2023.
  • Over 4 years, Revenue stood at $2.0 million in 2021, then fell by 1.7% to $2.0 million in 2022, then crashed by 87.38% to $248000.0 in 2023, then plummeted by 154.84% to -$136000.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at -$136000.0, -$815000.0, and -$809000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.